Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection.

A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection. Transplantation. 1987 Jan; 43(1):91-5.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.